Series A - Enalees

Series A - Enalees

Investment Firm

Overview

Enalees develops molecular diagnostic tests for pets that can be used directly by veterinarians.

Announced Date

Jul 27, 2024

Funding Type

Series A

Highlights

Location

Europe

Social

Investor Lead

Bpifrance

Bpifrance

Bpifrance is a debt and early_stage_venture and grant and private_equity and seed firm.

Participant Investors

1

Investor Name
Participant InvestorBpifrance

Round Details and Background

Enalees raised $16307255 on 2024-07-27 in Series A

Enalees develops molecular diagnostic tests for pets that can be used directly by veterinarians.

Company Funding History

2

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Oct 24, 2022
Grant - Enalees
-494.2K
Jul 27, 2024
Series A - Enalees
1-16.3M

Recent Activity

There is no recent news or activity for this profile.